Autoantibodies in chronic hepatitis C: A clinical perspective

Table 4 Prevalence of celiac disease autoantibodies in patients with chronic hepatitis C

Autoantibody	%	n	Country	Year	Ref.
AGA	32	82/359	United States	2001	Fine et al[142]
	11	11/104	Sweden	1997	Sjöberg et al[141]
	6.3	37/583	France multicenter	2007	Thevenot et al[145]
EmA/tTG	3.5	7/195	Italy	2004	Durante-Mangoni et al[14]
	2.0	5/244	Italy	2007	Ruggeri et al[36]
	1.2	3/259	United States	2001	Fine et al[142]
	0	0/210	Italy	2012	Gravina et al[35]
EmA	5.8	3/52	Brazil	2013	Marconcini et al[20]
	0.2	1/623	France multicenter	2007	Thevenot et al[145]
	0	0/195	United States	2008	Hernandez et al[40]
tTG	1	2/195	United States	2008	Hernandez et al[40]
	0	0/34	Brazil	2013	Marconcini et al[20]
	0	0/41	France multicenter	2007	Thevenot et al[145]

AGA: Antigliadin antibody; EmA: Anti-endomysial antibody; tTG: Tissue transglutaminase; EmA: Endomysial antibodies.